Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Lisa H. Butterfield(UPMC Hillman Cancer Center), Mary L. Disis(University of Washington), Hideaki Tahara(Yale University), Thomas-Oliver Kleen(Yale University), Samir N. Khleif(Georgetown University), Graham Pawelec(University of Tübingen), Cedrik M. Britten(Johannes Gutenberg University Mainz), Sjoerd H. van der Burg(Leiden University Medical Center), Sylvia Janetzki(Yale University), Theresa L. Whiteside(University of Pittsburgh), Jon M. Wigginton(Johns Hopkins University), Wenru Song(Pfizer (United States)), Giuseppe Masucci(Karolinska University Hospital), Leif Håkansson(Lund University), A. Karolina Palucka(Jackson Laboratory), Francesco M. Marincola(Refuge Biotechnologies (United States)), Bernard A. Fox(Oregon Health & Science University), Anatoli Malyguine(Science Applications International Corporation (United States)), Holden T. Maecker(Stanford University), Licia Rivoltini(Fondazione IRCCS Istituto Nazionale dei Tumori), David F. Stroncek(Yale University), Yutaka Kawakami(National Institutes of Health), Cristina Maccalli(Vita-Salute San Raffaele University), Giorgio Trinchieri(Frederick National Laboratory for Cancer Research), Peter P. Lee(Moffitt Cancer Center), Lupe G. Salazar(Yale University), Madhav V. Dhodapkar(Emory University), Craig L. Slingluff(University of Virginia), Douglas M. Potter(Yale University), Dolores J. Schendel(Medigene (Germany)), Vernon C. Maino(BD Biosciences (United States)), Michele Maio(University of Siena)

Clinical Cancer Research

May 11, 2011

Cited by 109

Related Papers

|New England Journal of Medicine|2012|12.6k

|New England Journal of Medicine|2012|8k

|New England Journal of Medicine|2011|7.7k

|New England Journal of Medicine|2013|4.2k

|Journal of Clinical Oncology|2014|2.2k